Drug-Eluting Stents in the Management of Coronary Artery Disease: Implications for Payors and Hospitals

ISSN： 1173-8790

Source： Disease Management & Health Outcomes, Vol.13, Iss.1, 2005-01, pp. : 1-7

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Current application and bioavailability of drug-eluting stents

By Escárcega Ricardo O Baker Nevin C Lipinski Michael J Magalhaes Marco A Minha Sa'ar Omar Al-Fazir Torguson Rebecca Waksman Ron

Expert Opinion on Drug Delivery, Vol. 11, Iss. 5, 2014-05 ,pp. : 689-709

Informa Healthcare

Access to resources Recommend Favorite

Cost-effectiveness of drug-eluting stents: real-world scrutiny of the BASKET trial of real-world usage

By Cooper Liesl M Linde-Zwirble Walter

Expert Opinion on Drug Delivery, Vol. 3, Iss. 3, 2006-05 ,pp. : 305-309

Informa Healthcare

Access to resources Recommend Favorite

Cost Effectiveness of Drug-Eluting Stents in Acute Myocardial Infarction Patients in Germany: Results from Administrative Data Using a Propensity Score-Matching Approach

By Bäumler Michael Stargardt Tom Schreyögg Jonas Busse Reinhard

Applied Health Economics and Health Policy, Vol. 10, Iss. 4, 2012-07 ,pp. : 235-248

Adis International

Access to resources Recommend Favorite

Drug-eluting polymer implants in cancer therapy

By Exner Agata A Saidel Gerald M

Expert Opinion on Drug Delivery, Vol. 5, Iss. 7, 2008-07 ,pp. : 775-788

Informa Healthcare

Access to resources Recommend Favorite

An Independent Practice Association-Supported Disease Management Program: Impact on Patients with Coronary Artery Disease

By Cannon-Wagner M. Soule D.S. Walker D.R. Vance R.P.

Disease Management & Health Outcomes, Vol. 10, Iss. 9, 2002-01 ,pp. : 571-577

Adis International

Access to resources Recommend Favorite